Cargando…

The mortality in infectious inpatients with type 2 diabetes compared with non-diabetic population: Infection in type 2 diabetes

The aim of the study was to determine the mortality in infectious inpatients with type 2 diabetes mellitus (T2DM) compared with non-diabetic population. A retrospective study was conducted on 13,916 infectious inpatients in The First Hospital of Qinhuangdao. Diabetic types were classified using Inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Chun-Ming, Yin, Fu-Zai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587657/
https://www.ncbi.nlm.nih.gov/pubmed/31192954
http://dx.doi.org/10.1097/MD.0000000000016025
_version_ 1783429112961957888
author Ma, Chun-Ming
Yin, Fu-Zai
author_facet Ma, Chun-Ming
Yin, Fu-Zai
author_sort Ma, Chun-Ming
collection PubMed
description The aim of the study was to determine the mortality in infectious inpatients with type 2 diabetes mellitus (T2DM) compared with non-diabetic population. A retrospective study was conducted on 13,916 infectious inpatients in The First Hospital of Qinhuangdao. Diabetic types were classified using International classification of Diseases-10. Mortality records were collected. The mortality was higher in patients with T2DM than patients without T2DM (T2DM 4.3% vs non-diabetes 1.7%, χ(2) = 59.560, P < .001). In multiple logistic regression analysis, T2DM was an independent risk factor of death in infectious inpatients (OR = 1.539, 95% CI: 1.181∼2.006, P = .001). The mortalities between those with T2DM and those without T2DM were stratified by age. The mortalities of patients with T2DM were 0.0% in ∼39 years, 0.0% in 40 to 49 years, 2.7% in 50 to 59 years, 3.1% in 60 to 69 years, 4.1% in 70 to 79 years and 8.7% in 80∼ years groups. The mortalities of patients without T2DM were 0.2% in ∼39 years, 0.1% in 40 to 49 years, 0.6% in 50 to 59 years, 1.0% in 60 to 69 years, 3.1% in 70 to 79 years and 5.9% in 80∼ years groups. T2DM was an independent risk factor of death only in 60 to 69 years groups (OR = 2.323, 95% CI: 1.234∼4.372, P = .009). The increase of mortality appears earlier in patients with T2DM. Infectious inpatients with T2DM are at increased risk of death and brings heavy economic burden to patients, society and government.
format Online
Article
Text
id pubmed-6587657
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-65876572019-06-24 The mortality in infectious inpatients with type 2 diabetes compared with non-diabetic population: Infection in type 2 diabetes Ma, Chun-Ming Yin, Fu-Zai Medicine (Baltimore) Research Article The aim of the study was to determine the mortality in infectious inpatients with type 2 diabetes mellitus (T2DM) compared with non-diabetic population. A retrospective study was conducted on 13,916 infectious inpatients in The First Hospital of Qinhuangdao. Diabetic types were classified using International classification of Diseases-10. Mortality records were collected. The mortality was higher in patients with T2DM than patients without T2DM (T2DM 4.3% vs non-diabetes 1.7%, χ(2) = 59.560, P < .001). In multiple logistic regression analysis, T2DM was an independent risk factor of death in infectious inpatients (OR = 1.539, 95% CI: 1.181∼2.006, P = .001). The mortalities between those with T2DM and those without T2DM were stratified by age. The mortalities of patients with T2DM were 0.0% in ∼39 years, 0.0% in 40 to 49 years, 2.7% in 50 to 59 years, 3.1% in 60 to 69 years, 4.1% in 70 to 79 years and 8.7% in 80∼ years groups. The mortalities of patients without T2DM were 0.2% in ∼39 years, 0.1% in 40 to 49 years, 0.6% in 50 to 59 years, 1.0% in 60 to 69 years, 3.1% in 70 to 79 years and 5.9% in 80∼ years groups. T2DM was an independent risk factor of death only in 60 to 69 years groups (OR = 2.323, 95% CI: 1.234∼4.372, P = .009). The increase of mortality appears earlier in patients with T2DM. Infectious inpatients with T2DM are at increased risk of death and brings heavy economic burden to patients, society and government. Wolters Kluwer Health 2019-06-14 /pmc/articles/PMC6587657/ /pubmed/31192954 http://dx.doi.org/10.1097/MD.0000000000016025 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Research Article
Ma, Chun-Ming
Yin, Fu-Zai
The mortality in infectious inpatients with type 2 diabetes compared with non-diabetic population: Infection in type 2 diabetes
title The mortality in infectious inpatients with type 2 diabetes compared with non-diabetic population: Infection in type 2 diabetes
title_full The mortality in infectious inpatients with type 2 diabetes compared with non-diabetic population: Infection in type 2 diabetes
title_fullStr The mortality in infectious inpatients with type 2 diabetes compared with non-diabetic population: Infection in type 2 diabetes
title_full_unstemmed The mortality in infectious inpatients with type 2 diabetes compared with non-diabetic population: Infection in type 2 diabetes
title_short The mortality in infectious inpatients with type 2 diabetes compared with non-diabetic population: Infection in type 2 diabetes
title_sort mortality in infectious inpatients with type 2 diabetes compared with non-diabetic population: infection in type 2 diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587657/
https://www.ncbi.nlm.nih.gov/pubmed/31192954
http://dx.doi.org/10.1097/MD.0000000000016025
work_keys_str_mv AT machunming themortalityininfectiousinpatientswithtype2diabetescomparedwithnondiabeticpopulationinfectionintype2diabetes
AT yinfuzai themortalityininfectiousinpatientswithtype2diabetescomparedwithnondiabeticpopulationinfectionintype2diabetes
AT machunming mortalityininfectiousinpatientswithtype2diabetescomparedwithnondiabeticpopulationinfectionintype2diabetes
AT yinfuzai mortalityininfectiousinpatientswithtype2diabetescomparedwithnondiabeticpopulationinfectionintype2diabetes